-
The Social Impact of Health (SIoH) Framework: Capturing How Health-Driven Productivity Shapes National Development
Sep 22, 2025, 16:24 PM -
Challenges in Assessing Trade-offs Between Efficiency and Equity in the Use of Digital Health Applications for Stroke Care
Sep 22, 2025, 16:24 PM -
Patient Engagement in Economic Evaluations of Cancer Care: Mapping the Landscape and Advancing Practice
Sep 22, 2025, 16:24 PM -
Defining "Value" in Digital Health Interventions: A Triangulated Approach to Model Development
Sep 22, 2025, 16:24 PM -
An Evaluation Framework for Healthcare Professionals’ Digital Health and AI Technologies: Evidence-Based Policy Recommendations
Sep 22, 2025, 16:24 PM -
EQ-5D Analysis in a Rare Disease: Utilities Across Disease Stages in Multiple-System Atrophy
Sep 22, 2025, 16:24 PM -
Utilizing LLMs to Enhance Patient-Reported Outcome Measures: Application to the EQ-5D and Bolt-ons
Sep 22, 2025, 16:24 PM -
No Strong Preference? Acceptance of the Quantitative Incorporation of Patient Preference in Economic Modeling in Past NICE Technology Appraisals
Sep 22, 2025, 16:24 PM -
Evaluating Personalized Care for Rare Disease: A Decision-Analytic Framework for Patient-Centered Solutions in Multiple System Atrophy
Sep 22, 2025, 16:24 PM -
Thus SPOKE the TA: Querying NICE Technology Assessments Using Generative AI and RAG
Sep 22, 2025, 16:24 PM -
Social and Economic Burden Among Patients With Inherited Retinal Disease: A Nationwide Matched Cohort Study in Sweden 2001-2021
Sep 22, 2025, 16:24 PM -
An Early Start: Preliminary Indirect Treatment Comparison Assessments Informing Evidence-Generation Planning for Joint Clinical Assessment
Sep 22, 2025, 16:24 PM -
Choosing Appropriate Population-Adjusted Indirect Comparison Methods for Health Technology Assessment: A Simulation Study on the Impact of Effect Modifiers Baseline Imbalances and Sample Size
Sep 22, 2025, 16:24 PM -
Exploring the Ability of Generative AI to Interpret and Report Comprehensive NMA Results: A Step Towards the Automation of NMA Reports
Sep 22, 2025, 16:24 PM -
Catalogue of Actions to Address Policy Barriers of Drug Repurposing
Sep 22, 2025, 16:24 PM -
Evolution of Risk-Sharing Agreements for Orphan Drugs 2015-2024
Sep 22, 2025, 16:24 PM -
Quality of Life and Utility Values Across the Alzheimer’s Disease Spectrum: Results From the What Matters Most Survey
Sep 22, 2025, 16:24 PM -
Cost-Effectiveness and Budget Impact of Gene Therapy for Eligible Patients With Sickle Cell Disease in the Netherlands
Sep 22, 2025, 16:24 PM -
Eliciting Preferences for Combination Vaccines Protecting Against Multiple Respiratory Viruses: A Cross-Sectional Discrete Choice Experiment of Adults Aged 50 in the US
Sep 22, 2025, 16:24 PM -
A Systematic Review of Economic Modeling Challenges and Proposed Solutions for Rare Disease Technologies: An HTAi RDIG Initiative
Sep 22, 2025, 16:24 PM
